Recombinant activated factor VII for diffuse alveolar hemorrhage in microscopic polyangiitis

Diffuse alveolar hemorrhage is a serious complication of the small vessel vasculitis syndromes and carries a high mortality. Recombinant activated factor VII (rFVIIa) is a powerful hemostatic agent developed for treatment of bleeding in patients with hemophilia and antibodies to factors VIII or IX....

Descripción completa

Detalles Bibliográficos
Autores principales: Mandal, S. K., Sagar, G., Sahoo, M., Jasuja, S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2012
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3391811/
https://www.ncbi.nlm.nih.gov/pubmed/22787316
http://dx.doi.org/10.4103/0971-4065.97134

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3391811/
https://www.ncbi.nlm.nih.gov/pubmed/22787316
http://dx.doi.org/10.4103/0971-4065.97134

Ejemplares similares